AstraZeneca is making flu safety extra handy with the launch of an at-home supply choice for FluMist, its nasal spray flu vaccine, the corporate introduced Friday.
Available on the market since 2003, FluMist was beforehand solely accessible at pharmacies or medical doctors’ places of work.
Starting Friday, eligible prospects can order it on-line and have it shipped on to their door, permitting dad and mom to vaccinate their kids at house with out photographs or a visit to the pharmacy.
The spray might be self-administered by adults as much as age 49, whereas caregivers may give it to kids ages 2–17, the corporate mentioned.
The FDA approved FluMist for self- and caregiver-administration in September 2024, after analysis confirmed adults over 18 might safely and successfully administer it to eligible people.
AstraZeneca hopes the needle-free choice and at-home comfort will enhance vaccination charges this 12 months.
Final 12 months’s flu season noticed the best variety of flu-related deaths for kids for a non-pandemic 12 months — 267 — for the reason that 2009 H1N1 pandemic, in response to the Centers for Disease Control and Prevention. Well being specialists stress that vaccination stays the perfect safety in opposition to the virus, although getting children vaccinated is usually a problem.
The CDC continues to advocate that everybody 6 months and older get a flu vaccine this fall.
Most medical insurance plans are anticipated to cowl the price, with a transport price for 4 FluMist doses estimated at beneath $10.
The corporate added for individuals who qualify, the nasal spray provides security and effectiveness corresponding to conventional flu photographs.
